ACTIVE

Curaevia

Export PDF

Financial year 2026 · Closed on 31/03/2026

Net result-24,3 k €-5 110,5 %over 1 year
Gross margin-5,8 k €-163,7 %over 1 year
Equity4,9 k €-83,3 %over 1 year

Identity

Source · BCE/KBO

Curaevia is a Private limited company incorporated in 2021. Its main activity is: Computer programming activities. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0760.948.865
Incorporation
07/01/2021
Legal form
Private limited company
Registered office
Ledebergstraat 67
9050 Gent · FlandreSee on map
Contributed capital
165 500,00 €
Latest accounts
31/03/2026

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20262025202420232022
Income statement
Gross margin-5,8 k €9,1 k €-7,5 k €-80,5 k €-40,1 k €
EBITDA-6,6 k €8,6 k €-8 k €-81,1 k €-40,5 k €
Operating result-24,1 k €642 €-12,4 k €-83,6 k €-40,5 k €
Net result-24,3 k €485 €-12,5 k €-83,7 k €-40,5 k €
Balance sheet
Equity4,9 k €29,2 k €28,7 k €41,2 k €9,5 k €
Total assets206,5 k €81,9 k €116,1 k €72,7 k €14,7 k €
Cash243,4 €16,4 k €6,5 k €8,5 k €9,7 k €
Debts198,1 k €50,8 k €85,4 k €31,5 k €5,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/03/2026

3 active · 2 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
PharmaLegal0541.432.719Represented by Georges DE FEU
Directorsince 05/06/2025
Pieter De Moor
Directorsince 05/06/2025
Etienne Maerien
Managing directorsince 30/12/2020

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Triple O Consulting & Investments0717.564.626Represented by Xavier Keters
Director01/02/2022 → 2024 accounts
Kriyaconsult0726.857.226Represented by Van Uytven Marc
Director30/12/2020 → 2024 accounts

Other companies at this address

Ledebergstraat 67 9050 Gent
CompanyCBE no.
CANTILIS● Active
0865.133.991
DRI3M● Active
0812.730.336
KLEIN BARNUM● Active
0462.189.954
LeapStation● Active
0688.732.761
PATRICK THIENPONT● Liquidation
0429.507.783

Full financial information

Source · NBB
20262025202420232022
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/04/202501/04/202401/04/202301/04/202207/01/2021
Closing of the financial year31/03/202631/03/202531/03/202431/03/202331/03/2022
Length of the financial year12 months12 months12 months12 months15 months
Filing date01/10/202602/10/202516/10/202431/10/202328/10/2022
General meeting30/09/202624/09/202525/09/202412/10/202330/09/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/03/202630/09/202601/10/2026DutchPDF
Micro model31/03/202524/09/202502/10/2025DutchPDF
Micro model31/03/202425/09/202416/10/2024DutchPDF
Micro model31/03/202312/10/202331/10/2023DutchPDF
Micro model31/03/202230/09/202228/10/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2026

3 active · 2 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
PharmaLegal0541.432.719Represented by Georges DE FEU
Directorsince 05/06/2025
Pieter De Moor
Directorsince 05/06/2025
Etienne Maerien
Managing directorsince 30/12/2020

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Triple O Consulting & Investments0717.564.626Represented by Xavier Keters
Director01/02/2022 → 2024 accounts
Kriyaconsult0726.857.226Represented by Van Uytven Marc
Director30/12/2020 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/03/2023
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/07/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/04/2022
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other11/01/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
PharmaLegal
Pieter De Moor
Etienne Maerien
Triple O Consulting & Investments
Kriyaconsult
2020202120222023202420252026
Curaevia
Ledebergstraat 67, 9050 Ledeberg (Gent)
Director
Director
Managing director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Ledebergstraat 67, 9050 Ledeberg (Gent)Current
accounts 2023 → 2026
Accounts 2026 · 2026-00550367
Visserij 172 bte A, 9000 Gent
accounts 2022
Accounts 2022 · 2022-20485850

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
CuraeviaCurrent
accounts 2022 → 2026
Accounts 2026 · 2026-00550367

Events

  1. 2026
    Annual accounts 2026-24,3 k €↓
  2. 2025
    Annual accounts 2025485 €↑
  3. 2024
    Annual accounts 2024-12,5 k €↑
  4. 2023
    Annual accounts 2023-83,7 k €↓
  5. 2022
    Annual accounts 2022-40,5 k €
  6. 07/01/2021
    IncorporationPrivate limited company